Preterm patent ductus arteriosus: A continuing conundrum for the neonatologist?

Seminars in Fetal and Neonatal Medicine

Volumn 20, Issue 4, 2015, Pages 272-277

  Evans, Nick ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Ductus arteriosus; Ibuprofen; Indomethacin; Infant premature; Systemic blood flow; Ultrasound

Indexed keywords

IBUPROFEN; INDOMETACIN; PARACETAMOL;

BLOOD VESSEL FUNCTION; CARDIAC IMAGING; DRUG CHOICE; DUCTUS ARTERIOSUS; ECHOCARDIOGRAPHY; HEART SURGERY; HUMAN; PALLIATIVE THERAPY; PATENT DUCTUS ARTERIOSUS; PATIENT CARE; PREMATURITY; PROPHYLAXIS; REVIEW; TIME TO TREATMENT; TREATMENT PLANNING; CLINICAL TRIAL (TOPIC); DUCTUS ARTERIOSUS, PATENT; ECHOGRAPHY; INFANT, PREMATURE, DISEASES; NEWBORN; PATHOPHYSIOLOGY; TIME;

CLINICAL TRIALS AS TOPIC; DUCTUS ARTERIOSUS, PATENT; ECHOCARDIOGRAPHY; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; TIME FACTORS;

EID: 84939562456     PISSN: 1744165X     EISSN: 18780946     Source Type: Journal    
DOI: 10.1016/j.siny.2015.03.004     Document Type: Review

References (43)

1. Evans N.J., Kluckow M. Early significant ductal shunting and intraventricular haemorrhage in ventilated preterm infants. Archs Dis Childh 1996, 75:F183-F186.
2. Kluckow M., Evans N.J. High pulmonary blood flow, the duct and pulmonary haemorrhage. J Pediatr 2000, 137:68-72.
3. Noori S., McCoy M., Friedlich P., Bright B., Gottipati V., Seri I., et al. Failure of ductus arteriosus closure is associated with increased mortality in preterm infants. Pediatrics 2009, 123:e138-e144.
4. De Waal K.A., Zonnenberg I. The definition of a hemodynamic significant duct in randomised controlled trials, a systematic literature review. J Paediatr Child Health 2011, 47(Suppl 1:A167):55.
5. Laughon M.M., Simmons M.A., Bose C.L. Patency of the ductus arteriosus in the premature infant: is it pathologic? Should it be treated?. Curr Opin Pediatr 2004, 16:146-151.
6. Bose C.L., Laughon M.M. Patent ductus arteriosus: lack of evidence for common treatments. Archs Dis Childh Fetal Neonatal Ed 2007, 92:F498-F502.
7. Benitz W.E. Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis?. J Perinatol 2010, 30:241-252.
8. Benitz W.E. Patent ductus arteriosus: to treat or not to treat?. Archs Dis Childh Fetal Neonatal Ed 2012, 97:F80-F82.
9. Evans N.J., Archer L.N.J. Postnatal circulatory adaptation in term and healthy preterm newborns. Archs Dis Childh 1990, 65:24-26.
10. Chu J., Clements A., Cotton E.K., Klaus M.H., Sweet A.Y., Tolley W.H. Neonatal pulmonary ischaemia. Part 1: clinical and physiological studies. Pediatrics 1967, 40:709-766.
11. Kluckow M., Evans N.J. Low superior vena cava flow and intraventricular haemorrhage in preterm infants. Archs Dis Childh 2000, 82:F188-F194.
12. Groves A.M., Kuschel C.A., Knight D.B., Skinner J.R. Does retrograde diastolic flow in the descending aorta signify impaired systemic perfusion in preterm infants?. Pediatr Res 2008, 63:89-94.
13. Ohlsson A., Walia R., Shah S.S. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2013, (4):CD003481.
14. Hirt D., Van Overmeire B., Treluyer J.M., Langhendries J.P., Marguglio A., Eisinger M.J., et al. An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic study. Br J Clin Pharmacol 2008, 65:629-636.
15. Dani C., Vangi V., Bertini G., Pratesi S., Lori I., Favelli F., et al. High-dose ibuprofen for patent ductus arteriosus in extremely preterm infants: a randomized controlled study. Clin Pharmacol Ther 2012, 91:590-596.
16. Gokmen T., Erdeve O., Altug N., Oguz S.S., Uras N., Dilmen U. Efficacy and safety of oral versus intravenous ibuprofen in very low birth weight preterm infants with patent ductus arteriosus. J Pediatr 2011, 158. 549-554.e1.
17. Tammela O., Ojala R., Iivainen T., Lautamatti V., Pokela M.L., Janas M., et al. Short vs prolonged indomethacin therapy for patent ductus arteriosus in preterm infants. J Pediatr 1999, 134:552-557.
18. Carmo-Browning C., Paradisis M., Evans N. Randomised trial of echocardiographically directed duration of indomethacin treatment for patent ductus arteriosis in very preterm babies. J Pediatr 2009, 155. 819-822.e1.
19. Keller R.L., Clyman R.I. Persistent Doppler flow predicts lack of response to multiple courses of indomethacin in premature infants with recurrent patent ductus arteriosus. Pediatrics 2003, 112(3 Pt 1):583-587.
20. Hammerman C., Bin-Nun A., Markovitch E., Schimmel M.S., Kaplan M., Fink D. Ductal closure with paracetamol: a surprising new approach to patent ductus arteriosus treatment. Pediatrics 2011, 128:e1618-e1621.
21. Dang D., Wang D., Zhang C., Zhou W., Wu H. Comparison of oral paracetamol vs ibuprofen in premature infants with patent ductus arteriosus: a randomised controlled trial. PLoS One 2013, 8. e77888.
22. Oncel M.Y., Yurttutan S., Erdeve O., Uras N., Altug N., Oguz S.S., et al. Oral paracetamol versus oral ibuprofen in the management of patent ductus arteriosus in preterm infants: a randomized controlled trial. J Pediatr 2014, 164. 510-514.e1.
23. Yeh T.F., Luken J.A., Thalji A., Raval D., Carr I., Pildes R.S. Intravenous indomethacin therapy in premature infants with persistent ductus arteriosus - a double-blind controlled study. J Pediatr 1981, 98:137-145.
24. Yanagi R.M., Wilson A., Newfeld E.A., Aziz K.U., Hunt C.E. Indomethacin treatment for symptomatic patent ductus arteriosus: a double-blind control study. Pediatrics 1981, 67:647-652.
25. Merritt T.A., Harris J.P., Roghmann K., Wood B., Campanella V., Alexson C., et al. Early closure of the patent ductus arteriosus in very low-birth-weight infants: a controlled trial. J Pediatr 1981, 99:281-286.
26. Rudd P., Montanez P., Hallidie-Smith K., Silverman M. Indomethacin treatment for patent ductus arteriosus in very low birthweight infants: double blind trial. Archs Dis Childh 1983, 58:267-270.
27. Gersony W.M., Peckham G.J., Ellison R.C., Miettinen O.S., Nadas A.S. Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. J Pediatr 1983, 102:895-906.
28. Mahony L., Carnero V., Brett C., Heymann M., Clyman R. Prophylactic indomethacin therapy for patent ductus arteriosus in very-low-birthweight infants. N Engl J Med 1982, 306:506-510.
29. Hammerman C., Strates E., Komar K., Kim-chi B. Failure of prophylactic indomethacin to improve the outcome of the very low birth weight infant. Dev Pharmacol Ther 1987, 10:393-404.
30. Weesner K., Dillard R., Boyle R., Block S. Prophylactic treatment of asymptomatic patent ductus arteriosus in premature infants with respiratory distress syndrome. Southern Med J 1987, 80:706-708.
31. Aranda J.V., Clyman R., Cox B., Van Overmeire B., Wozniak P., Sosenko I., et al. A randomized, double-blind, placebo-controlled trial on intravenous ibuprofen l-lysine for the early closure of nonsymptomatic patent ductus arteriosus within 72 hours of birth in extremely low-birth-weight infants. Am J Perinatol 2009, 26:235-245.
32. Van Overmeire B., Van de Broek H., Van Laer P., Weyler J., Vanhaesebrouck P. Early versus late indomethacin treatment for patent ductus arteriosus in premature infants with respiratory distress syndrome. J Pediatr 2001, 138:205-211.
33. Kluckow M., Jeffery M., Gill A., Evans N. A randomised placebo-controlled trial of early treatment of the patent ductus arteriosus. Archs Dis Childh Fetal Neonatal Ed 2014, 99:F99-F104.
34. Fowlie P.W., Davis P.G., McGuire W. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev 2010, (7):CD000174.
35. Ohlsson A., Shah S.S. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2006, (1):CD004213.
36. Cooke L., Steer P.A., Woodgate P.G. Indomethacin for asymptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev 2003, (1):CD003745.
37. Vohr B.R., Allan W.C., Westerveld M., Schneider K.C., Katz K.H., Makuch R.W., et al. School-age outcomes of very low birth weight infants in the indomethacin intraventricular hemorrhage prevention trial. Pediatrics 2003, 111:e340-e346.
38. Schmidt B., Davis P., Moddemann D., Ohlsson A., Roberts R.S., Saigal S., et al. Trial of Indomethacin Prophylaxis in Preterms Investigators. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med 2001, 344:1966-1972.
39. Alfaleh K., Smyth J.A., Roberts R.S., Solimano A., Asztalos E.V., Schmidt B. Trial of Indomethacin Prophylaxis in Preterms Investigators. Prevention and 18-month outcomes of serious pulmonary hemorrhage in extremely low birth weight infants: results from the trial of indomethacin prophylaxis in preterms. Pediatrics 2008, 121:e233-e238.
40. Jhaveri N., Moon-Grady A., Clyman R.I. Early surgical ligation versus a conservative approach for management of patent ductus arteriosus that fails to close after indomethacin treatment. J Pediatr 2010, 157. 381-387.e1.
41. McNamara P.J., Stewart L., Shivananda S.P., Stephens D., Sehgal A. Patent ductus arteriosus ligation is associated with impaired left ventricular systolic performance in premature infants weighing less than 1000 g. J Thoracic Cardiovasc Surg 2010, 140:150-157.
42. Noori S., Friedlich P., Seri I., Wong P. Changes in myocardial function and hemodynamics after ligation of the ductus arteriosus in preterm infants. J Pediatr 2007, 150:597-602.
43. Kabra N.S., Schmidt B., Roberts R.S., Doyle L.W., Papile L., Fanaroff A. Trial of Indomethacin Prophylaxis in Preterms Investigators. Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: results from the Trial of Indomethacin Prophylaxis in Preterms. J Pediatr 2007, 150. 229-234, 234.e1.